Finance

Lists
MED:NYSE
Medifast Inc
11,67 US$
+0,43%
(+0,050) 1D
11,67 US$
0,00% (0,00)
After hours
Closed: 13 ოქტ, 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MED...
Open
11,60 US$
High
11,79 US$
Low
11,51 US$
Mkt. cap
130,48 მლნ.
Avg. vol.
111,72 ათ.
Volume
102,76 ათ.
52-wk high
13,58 US$
52-wk low
9,22 US$
EPS
-2,33 US$
Beta
0,68
Shares outstanding
11,18 მლნ.
No. of employees
380
Open
11,60 US$
High
11,79 US$
Low
11,51 US$
Mkt. cap
130,48 მლნ.
Avg. vol.
111,72 ათ.
Volume
102,76 ათ.
52-wk high
13,58 US$
52-wk low
9,22 US$
EPS
-2,33 US$
Beta
0,68
Shares outstanding
11,18 მლნ.
No. of employees
380
News stories
From web sources and news partners
Profile
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. Wikipedia
About Medifast Inc
CEOდანიელ არ ჩარდ | დანიელ არ ჩარდ
Employees380
Founded1981
Headquarters-
SectorPersonal care products
Analyst ratings
Based on 1 analyst giving stock ratings to MED in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MED in the last 3 months
Highest
Current 11,67 US$
12,00 US$ (+2,83%)
Average
12,00 US$ (+2,83%)
Lowest
12,00 US$ (+2,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jim Salera
Stephens
Hold
Maintained
12,00 US$
+2,8%
08/04/2026
Last report
3 აგვ. 2026
Fiscal period
Q2 2026
-0,28 US$ / -0,65 US$
+56,92%beat
Revenue / Est. (USD)
76,38 მლნ. / 72,70 მლნ.
+5,07%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
89,41 მლნ.
75,10 მლნ.
76,04 მლნ.
76,38 მლნ.
Cost of goods sold
27,25 მლნ.
22,96 მლნ.
24,29 მლნ.
22,99 მლნ.
Cost of revenue
27,25 მლნ.
22,96 მლნ.
24,29 მლნ.
22,99 მლნ.
Research and development expenses
1,10 მლნ.
1,00 მლნ.
1,10 მლნ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65,14 მლნ.
58,94 მლნ.
56,14 მლნ.
57,72 მლნ.
Operating expense
66,24 მლნ.
59,94 მლნ.
57,24 მლნ.
57,72 მლნ.
Total operating expenses
93,49 მლნ.
82,90 მლნ.
81,52 მლნ.
80,71 მლნ.
Operating income
-4,08 მლნ.
-7,80 მლნ.
-5,48 მლნ.
-4,33 მლნ.
Other non operating income
-2,00 ათ.
1,00 ათ.
16,00 ათ.
-11,00 ათ.
EBT including unusual items
-2,66 მლნ.
-6,38 მლნ.
-1,94 მლნ.
-2,99 მლნ.
EBT excluding unusual items
-2,66 მლნ.
-6,38 მლნ.
-4,08 მლნ.
-2,99 მლნ.
Income tax expense
-396,00 ათ.
11,74 მლნ.
181,00 ათ.
109,00 ათ.
Effective tax rate
14,90%
-183,91%
-9,32%
-3,64%
Other operating expenses
-
-
-
-
Net income
-2,26 მლნ.
-18,12 მლნ.
-2,12 მლნ.
-3,10 მლნ.
Net profit margin
-2,53%
-24,13%
-2,79%
-4,06%
Earnings per share
-0,21
-1,65
-0,19
-0,28
Interest and investment income
1,43 მლნ.
1,42 მლნ.
1,38 მლნ.
1,35 მლნ.
Interest expense
-
-
-
-
Net interest expenses
1,43 მლნ.
1,42 მლნ.
1,38 მლნ.
1,35 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-629,00 ათ.
-4,34 მლნ.
-2,00 მლნ.
-881,00 ათ.
Gain or loss from assets sale
606,00 ათ.
372,00 ათ.
-2,12 მლნ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები